Antidepressants increased the risk of suicidal thoughts and behavior in
children, adolescents, and young adults in short-term studies.
These studies did not show an increase in the risk of suicidal thoughts
and behavior with antidepressant use in patients over age 24; there was a
reduction in risk with antidepressant use in patients aged 65 and older.
In patients of all ages who are started on antidepressant therapy, monitor
closely for worsening, and for emergence of suicidal thoughts and behaviors.
Advise families and caregivers of the need for close observation and
communication with the prescriber.
FETZIMA is not approved for use in pediatric patients.